Combating Rubber Cancer: Exploring the Path to Treatment
Rubber tumours are a tumour within the skull that poses a serious threat to human health and are of great concern because of their aggressive nature, the high rate of relapse and the difficulty of treatment. This paper will explore in depth the treatment of gelatinoma and provide some useful information and hope for patients and their families.
I. OVERVIEW OF THE GRAMMA
Rubber tumours are tumours originating in neurogel cells, which can be classified as low-level gel tumours and high-level gel tumours according to their pathologies. Low-level gel tumours grow relatively slowly and predict better; high-level gel tumours are highly invasive, growing rapidly and are expected to be poor. Symptoms of glucose tumours include, inter alia, headaches, vomiting, visual impairment, physical incapacitation, etc. The symptoms are associated with the location, size and growth rate of the tumor.
II. Surgery
Surgical surgery is one of the most important tools for the treatment of geloma. The aim is to remove the tumour tissue to the extent possible, to reduce the tumour pressure on the normal brain tissue around it and to mitigate the symptoms, and to identify the pathology of the tumour and provide the basis for subsequent treatment.
1. The principle of surgery, to the extent possible and subject to the safety of the patient, to remove the tumour tissue. In the case of low-level gelatinoma, complete removal can be sought if the tumor is located in a non-functional area, and in the case of high-level gelatinoma, due to its aggressive nature, it is difficult to achieve complete removal, generally with maximum tumour removal.
2. Surgery risks. There are certain risks to the treatment of gel tumours, such as haemorrhage, infection, neurological impairment, etc. Thus, prior to the operation, the doctor conducts a comprehensive assessment of the patient and develops a detailed surgical programme to reduce the risk of the operation.
3. The effect of the operation. The treatment can significantly alleviate the symptoms and improve the quality of life of the patients. In the case of low-level gel tumours, the life of the patient after the surgery is longer; in the case of high-level gel tumours, although not entirely cured, the operation may extend the life of the patient and buy time for subsequent treatment.
Radiotherapy
Radiotherapy is an important component of the integrated treatment of rubber tumors. It is based on the use of high-energy rays to kill tumour cells and inhibit tumour growth.
1. Treatment
(1) Exterior exposure treatment: The most common form of release is irradiation of tumours by irradiating the tumour by irradiating the tumour by irradiating the tumour with the irradiation equipment.
(2) Internal exposure is administered: radioactive particles are implanted inside or around the tumour, and the tumour is continuously released and exposed.
2. The timing of the treatment is generally performed after the operation, and radiotherapy may also be provided to patients who cannot be operated separately.
Radiotherapy may cause some side effects, such as hair loss, nausea, vomiting, inactivity, skin damage, etc. These side effects are usually gradually reduced after the end of treatment.
Radiotherapy can effectively control the growth of gelatinoma and prolong the patient’s life. In the case of high-level glaucoma, combined operation and chemotherapy can improve treatment effectiveness.
IV. Chemical treatment
Chemical treatment is a cure for the use of chemical drugs to kill tumour cells.
1. Chemical drugs are currently commonly used in the form of methamine, Carmostin and Lomostine. These drugs can be used alone or jointly.
2. The timing of chemotherapy is usually performed after the operation, and it is also possible for patients who cannot be operated on alone.
3. The side effects of chemotherapy may have some side effects on the body, such as nausea, vomiting, hair loss, bone marrow inhibition, etc. Doctors adjust drug doses and treatment programmes to the specific circumstances of the patient to mitigate side effects.
4. The effects of chemotherapy The chemical treatment can effectively control the growth of gel tumours and prolong the life of the patient. In the case of high-level gel tumours, the combination of chemotherapy operations and treatment can improve the effectiveness of treatment.
V. Target treatment
Target-oriented treatment is a treatment for a specific molecular target on a tumor. The target-oriented treatment of glyphosma is directed primarily at specific proteins or signals on the surface of the tumour cell, and the growth of tumour cells is inhibited by the use of target-to-drugs to disrupt the activity of these proteins or signals.
1. Target-oriented drugs, which are currently being used for the treatment of rubber tumours, are those that are resistant to Baylor, Eroteini, Gifidini, etc. These drugs can be used alone or in combination with chemotherapy or leachate.
2. Target-to-treatment. Target-to-treatment can increase the efficacy of the treatment of rubber tumours and prolong the patient ‘ s life. However, due to the heterogeneity of the adhesive tumour, the response of different patients to the target-to-pharmaceuticals varies considerably, and the choice of the appropriate target-to-pharmaceutical drugs needs to be tailored to the specific circumstances of the patient.
VI. Immunotherapy
Immunisation treatment is a treatment against tumours by activation of the patient ‘ s own immune system. The immunisation treatment of glaucoma includes, inter alia, treatment of immunosuppressants, treatment of oncology vaccines, and treatment of continuity cell immunisation.
1. Immunosuppressant treatment. Immunosuppressants can disrupt tumour cells ‘ inhibition of the immune system and enhance its ability to attack tumour cells. Immuno-censorship inhibitors currently used for the treatment of rubber tumours are Pablo and Navulillo.
Oncological vaccines are a cure for identifying and attacking tumour cells by activation of the patient’s immune system. Oncological vaccines currently used for the treatment of gelatinoma include platinum, spectrocyte, etc.
3. Physicular immunisation treatment is the in vitro training and expansion of the immunocellular cells of the patient himself or in another form, and is then transferred back to the patient, enhancing the ability of the patient ‘ s immune system to attack tumour cells. There are T-cell treatments, NK-cell treatments, and so on.
Immunotherapy has shown some potential in the treatment of rubber tumours, but it is still at the clinical stage and its effectiveness needs further validation.
Comprehensive treatment
Owing to the complexity and difficulty of the treatment of rubber tumours, it is often difficult for a single treatment to achieve satisfactory results. Thus, integrated treatment is the main strategy for the current treatment of glued tumours. Comprehensive treatment includes a combination of surgical, therapeutic, chemotherapy, target-oriented and immunotherapy treatments, and individualized treatment programmes tailored to the specific circumstances of the patient are designed to enhance the effectiveness of the treatment and to extend the life of the patient.
VIII. REHABILIZATION
The treatment is often followed by neurofunctional disorders, such as physical incapacitation, speech impairment, cognitive impairment, etc. Rehabilitation can help patients to recover their nervous function and improve their quality of life. Rehabilitation treatment includes physiotherapy, occupational therapy, speech therapy, cognitive therapy, etc.
IX. Summary
Rubber tumours are a serious tumour in the skull and are difficult to treat. At present, a variety of treatments such as surgery, treatment, chemotherapy, target treatment and immunotherapy play an important role in the treatment of gelatinoma. Integrated treatment is the main strategy for the treatment of glued tumours, and the development of individualized treatment programmes, tailored to the specific circumstances of the patient, can improve the effectiveness of treatment and prolong the life of the patient. At the same time, rehabilitation can help patients to recover their nervous function and improve their quality of life. As medical technology continues to improve, it is believed that more and more effective treatments will emerge in the near future, giving new hope to patients with geloma.
Brain aneurysm. Neural intervention.
